{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:26:20Z","timestamp":1760955980266,"version":"3.40.5"},"reference-count":19,"publisher":"Bentham Science Publishers Ltd.","issue":"2","license":[{"start":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T00:00:00Z","timestamp":1575590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHAMC"],"published-print":{"date-parts":[[2019,12,6]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Recent findings have shown that in Acute Ischemic Stroke (AIS) patients,\nelevated troponin is associated with increased mortality. However, due to concerns of cerebral hypoperfusion\nand hemorrhagic transformation, current practice has been slow to apply proven cardiac\ntherapies to these patients. This study aims to determine this rate of utilization.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>A single-center review of 83 patients with AIS and measured troponin was\nconducted. Patients were stratified based on elevated and non-elevated troponin. Between groups, we\nmeasured the utilization of evidence-based cardiac therapies and used a univariate logistic regression\nto compare outcomes of mortality, re-hospitalization, recurrent acute ischemic stroke, recurrent acute\nmyocardial infarction, and a composite of these outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Of 83 patients, 25 had elevated troponin and 58 had non-elevated troponin. There was no\nstatistical difference in the use of cardiac therapies between the two groups. Adenosine diphosphate\nP2Y12 antagonists were infrequently used in both elevated and non-elevated troponin groups at 32%\nvs. 24% (p = 0.64), as were Angiotensin-Converting Enzyme Inhibitors (ACE-I) and angiotensin II\nreceptor blockers (ARB) at 56% vs. 69% (p = 0.38). Those in the elevated troponin group encountered\na statistically significant increase in composite endpoint 64% vs. 33% (Odds Ratio [OR] 7.28,\n95% Confidence interval [CI] 2.19-28.88, p&lt;0.01).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Cardiac therapies are underutilized in patients with acute ischemic stroke and elevated\ntroponin levels. In turn, this low usage may explain the increase in morbidity and mortality seen in\nthese patients and the use of such therapies should be considered when treating this subset of patients\nas the cardio protective nature of these therapies may outweigh the risks associated with them in AIS\npatients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871525717666191019115338","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T07:58:52Z","timestamp":1571558332000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Underutilization of Cardiac Therapies in Patients with Acute Ischemic Stroke and Elevated Troponin"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8538-7448","authenticated-orcid":true,"given":"Michael","family":"He","sequence":"first","affiliation":[{"name":"Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7116-792X","authenticated-orcid":true,"given":"Subhasree","family":"Panchangam","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Cruz","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3694","authenticated-orcid":true,"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Texas Tech University Health Sciences Center, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1212\/WNL.41.6.855","volume":"41","author":"Bogousslavsky J.","year":"1991","unstructured":"Bogousslavsky J.; Cachin C.; Regli F.; Despland P.A.; Van Melle G.; Kappenberger L.; Cardiac sources of embolism and cerebral infarction--clinical consequences and vascular concomitants: the Lausanne Stroke Registry. Neurology 1991,41(6),855-859","journal-title":"Neurology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1161\/STROKEAHA.106.471813","volume":"38","author":"Prosser J.","year":"2007","unstructured":"Prosser J.; MacGregor L.; Lees K.R.; Diener H.C.; Hacke W.; Davis S.; Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007,38(8),2295-2302","journal-title":"Stroke"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5603\/CJ.a2015.0058","volume":"23","author":"Diez M.","year":"2016","unstructured":"Diez M.; Talavera M.L.; Conde D.G.; Campos R.; Acosta A.; Trivi M.S.; High-sensitivity troponin is associated with high risk clinical profile and outcome in acute heart failure. Cardiol J 2016,23(1),78-83","journal-title":"Cardiol J"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/STROKEAHA.116.014561","volume":"48","author":"Wrigley P.","year":"2017","unstructured":"Wrigley P.; Khoury J.; Eckerle B.; Alwell K.; Moomaw C.J.; Woo D.; Flaherty M.L.; De Los Rios la Rosa F.; Mackey J.; Adeoye O.; Martini S.; Ferioli S.; Kissela B.M.; Kleindorfer D.O.; Prevalence of positive troponin and echocardiogram findings and association with mortality in acute ischemic stroke. Stroke 2017,48(5),1226-1232","journal-title":"Stroke"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.117.005905","volume":"6","author":"Merkler A.E.","year":"2017","unstructured":"Merkler A.E.; Gialdini G.; Murthy S.B.; Salehi Omran S.; Moya A.; Lerario M.P.; Chong J.; Okin P.M.; Weinsaft J.W.; Safford M.M.; Fink M.E.; Navi B.B.; Iadecola C.; Kamel H.; Association between troponin levels and embolic stroke of undetermined source. J Am Heart Assoc 2017,6(9),1-7","journal-title":"J Am Heart Assoc"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"Amsterdam E.A.","year":"2014","unstructured":"Amsterdam E.A.; Wenger N.K.; Brindis R.G.; Casey D.E.; Ganiats T.G.; Holmes D.R.; Jaffe A.S.; Jneid H.; Kelly R.F.; Kontos M.C.; Levine G.N.; Liebson P.R.; Mukherjee D.; Peterson E.D.; Sabatine M.S.; Smalling R.W.; Zieman S.J.; 2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014,64(24),e139-e228","journal-title":"J Am Coll Cardiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ije\/dyq165","volume":"40","author":"Mendis S.","year":"2011","unstructured":"Mendis S.; Thygesen K.; Kuulasmaa K.; Giampaoli S.; M\u00e4h\u00f6nen M.; Ngu Blackett K.; Lisheng L.; World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011,40(1),139-146","journal-title":"Int J Epidemiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1161\/01.STR.17.5.861","volume":"17","author":"Britton M.","year":"1986","unstructured":"Britton M.; Carlsson A.; de Faire U.; Blood pressure course in patients with acute stroke and matched controls. Stroke 1986,17(5),861-864","journal-title":"Stroke"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1161\/01.STR.0000014509.11540.66","volume":"33","author":"Leonardi-Bee J.","year":"2002","unstructured":"Leonardi-Bee J.; Bath P.M.; Phillips S.J.; Sandercock P.A.; Blood pressure and clinical outcomes in the international stroke trial. Stroke 2002,33(5),1315-1320","journal-title":"Stroke"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/STROKEAHA.108.531574","volume":"40","author":"Aiyagari V.","year":"2009","unstructured":"Aiyagari V.; Gorelick P.B.; Management of blood pressure for acute and recurrent stroke. Stroke 2009,40(6),2251-2256","journal-title":"Stroke"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"Powers W.J.","year":"2018","unstructured":"Powers W.J.; Rabinstein A.A.; Ackerson T.; Adeoye O.M.; Bambakidis N.C.; Becker K.; Biller J.; Brown M.; Demaerschalk B.M.; Hoh B.; Jauch E.C.; Kidwell C.S.; Leslie-Mazwi T.M.; Ovbiagele B.; Scott P.A.; Sheth K.N.; Southerland A.M.; Summers D.V.; Tirschwell D.L.; 2018 guidelines for the early management of patients with acute ischemic stroke. Stroke 2018,49(3),e46-e110","journal-title":"Stroke"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1474-4422(10)70060-0","volume":"9","author":"Wong K.S.L.","year":"2010","unstructured":"Wong K.S.L.; Chen C.; Fu J.; Chang H.M.; Suwanwela N.C.; Huang Y.N.; Han Z.; Tan K.S.; Ratanakorn D.; Chollate P.; Zhao Y.; Koh A.; Hao Q.; Markus H.S.; Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010,9(5),489-497","journal-title":"Lancet Neurol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","volume":"111","author":"Markus H.S.","year":"2005","unstructured":"Markus H.S.; Droste D.W.; Kaps M.; Larrue V.; Lees K.R.; Siebler M.; Ringelstein E.B.; Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005,111(17),2233-2240","journal-title":"Circulation"},{"key":"ref=14","first-page":"349","volume":"2","year":"1988","unstructured":"Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988,2(8607),349-360","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJMoa0909475","volume":"363","author":"Mehta S.R.","year":"2010","unstructured":"Mehta S.R.; Bassand J.P.; Chrolavicius S.; Diaz R.; Eikelboom J.W.; Fox K.A.; Granger C.B.; Jolly S.; Joyner C.D.; Rupprecht H.J.; Widimsky P.; Afzal R.; Pogue J.; Yusuf S.; Macaya C.; Di Pasquale G.; Niemela K.; Ajani A.E.; White H.D.; Chrolavicius S.; Gao P.; Fox K.A.; Yusuf S.; Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010,363(10),930-942","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0828-282X(08)70669-X","volume":"24","author":"Fitchett D.H.","year":"2008","unstructured":"Fitchett D.H.; Goodman S.G.; Langer A.; Ischemic stroke: A cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Can J Cardiol 2008,24(9),705-708","journal-title":"Can J Cardiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Wang Y.","year":"2013","unstructured":"Wang Y.; Wang Y.; Zhao X.; Liu L.; Wang D.; Wang C.; Wang C.; Li H.; Meng X.; Cui L.; Jia J.; Dong Q.; Xu A.; Zeng J.; Li Y.; Wang Z.; Xia H.; Johnston S.C.; Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013,369(1),11-19","journal-title":"N Engl J Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7326\/0003-4819-159-7-201310010-00006","volume":"159","author":"Lee M.","year":"2013","unstructured":"Lee M.; Saver J.L.; Hong K.S.; Rao N.M.; Wu Y.L.; Ovbiagele B.; Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med 2013,159(7),463-470","journal-title":"Ann Intern Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"Johnston S.C.","year":"2018","unstructured":"Johnston S.C.; Easton J.D.; Farrant M.; Barsan W.; Conwit R.A.; Elm J.J.; Kim A.S.; Lindblad A.S.; Palesch Y.Y.; Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 2018,379(3),215-225","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular &amp; Hematological Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/175892","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/175892\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/175892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T10:42:35Z","timestamp":1625136155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/175892\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871525717666191019115338","relation":{},"ISSN":["1871-5257"],"issn-type":[{"type":"print","value":"1871-5257"}],"subject":[],"published":{"date-parts":[[2019,12,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}